The contribution of cardiac myosin binding protein-c Ser282 phosphorylation to the rate of force generation and in vivo cardiac contractility.
about
Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathyCardiac MyBP-C regulates the rate and force of contraction in mammalian myocardiumMYBPC1, an Emerging Myopathic Gene: What We Know and What We Need to LearnLength-dependent changes in contractile dynamics are blunted due to cardiac myosin binding protein-C ablation.Myosin-binding protein C corrects an intrinsic inhomogeneity in cardiac excitation-contraction coupling.Molecular effects of the myosin activator omecamtiv mecarbil on contractile properties of skinned myocardium lacking cardiac myosin binding protein-CCardiac Myosin Binding Protein-C Phosphorylation Modulates Myofilament Length-Dependent ActivationMolecule specific effects of PKA-mediated phosphorylation on rat isolated heart and cardiac myofibrillar functionCardiac myosin binding protein-C Ser302 phosphorylation regulates cardiac β-adrenergic reserveThe contributions of cardiac myosin binding protein C and troponin I phosphorylation to β-adrenergic enhancement of in vivo cardiac function.Phosphoregulation of Cardiac Inotropy via Myosin Binding Protein-C During Increased Pacing Frequency or β1-Adrenergic Stimulation.Sarcomeric protein modification during adrenergic stress enhances cross-bridge kinetics and cardiac output.β-Adrenergic augmentation of cardiac contractility is dependent on PKA-mediated phosphorylation of myosin-binding protein C and troponin I.Phosphorylation of cardiac myosin binding protein-C regulates heart contraction and dilatation in vivo during β-adrenergic receptor activation.Impact of the Myosin Modulator Mavacamten on Force Generation and Cross-Bridge Behavior in a Murine Model of Hypercontractility
P2860
Q26799594-AF39C610-DC8E-4C4C-AA4B-3CABDAD4880FQ27011328-BC342184-8BA8-4F44-9238-CE21A055FDADQ28070076-32DF2CD6-C703-486E-8A06-BA67659713ADQ34608313-EBD4C64D-FEDF-4414-93B9-C97862F207D9Q35234607-5553B6E3-46BC-469E-92A5-837F2882B073Q36341946-47548DDF-80A5-4890-9D3E-CA192D4C8452Q36579173-171711EF-C0C9-4509-865C-C6F7201D8A7CQ36984198-DAB4A3F6-E5E9-4B60-81EF-DF51C0CDD086Q37693685-DF554DD6-83B5-4F6B-9FB4-BC7042058AA5Q40243911-87C08D06-4875-4A02-891B-3770697D76B2Q40902689-FA0C0197-1A66-47AD-9F87-33A8B60DD2B3Q51291160-096E4E56-CC0C-4DAE-BCE4-690C1D655F06Q51539830-CEE7CC7C-5332-4AAE-8B42-9D86DB19094BQ51641005-FE095310-DE82-4911-9962-87C484B5859EQ58127428-CD27EBFE-0EBB-4FB7-BE3C-6DB96C39FA4A
P2860
The contribution of cardiac myosin binding protein-c Ser282 phosphorylation to the rate of force generation and in vivo cardiac contractility.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The contribution of cardiac my ...... in vivo cardiac contractility.
@en
The contribution of cardiac my ...... in vivo cardiac contractility.
@nl
type
label
The contribution of cardiac my ...... in vivo cardiac contractility.
@en
The contribution of cardiac my ...... in vivo cardiac contractility.
@nl
prefLabel
The contribution of cardiac my ...... in vivo cardiac contractility.
@en
The contribution of cardiac my ...... in vivo cardiac contractility.
@nl
P2093
P2860
P1476
The contribution of cardiac my ...... in vivo cardiac contractility.
@en
P2093
Julian E Stelzer
Kenneth S Gresham
Ranganath Mamidi
P2860
P304
P356
10.1113/JPHYSIOL.2014.276022
P407
P577
2014-06-20T00:00:00Z